Jihang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jihang Chen has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Daozheng Fang
The Chinese University of Hong Kong
14 shared publicationsYong Zhu
The Chinese University of Hong Kong
13 shared publicationsZhihao Liu
The Chinese University of Hong Kong
13 shared publicationsHaimeng Li
The Chinese University of Hong Kong
9 shared publications- Jianping Chen
Shenzhen Key Laboratory of Hospital Chinese Medicine Preparation, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518033, China
9 shared publications Juanjuan Cheng
The Chinese University of Hong Kong
9 shared publications
Latest Publications
- 24 October 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (43) , 33872-33887
Oleanolic Acid and Ursolic Acid Alleviate Obesity-Induced Skeletal Muscle Atrophy via Activation of the IRS/PI3K/AKT/mTOR Signaling Pathway and Attenuation of Oxidative Stress
Oleanolic acid (OA) and ursolic acid (UA) are dietary pentacyclic triterpenoids with anti-inflammatory and insulin-sensitizing properties, but their comparative effects on obesity-related skeletal muscle atrophy remain unclear. In this study, high-fat diet-fed C57BL/6J mice and palmitic acid-treated C2C12 cells were used to evaluate their efficacy and mechanisms. OA and UA improved glucose homeostasis, attenuated muscle atrophy, and alleviated dyslipidemia and inflammation. Mechanistically, both compounds activated IRS/AKT/mTOR signaling, suppressed GSK-3β/FOXO1-mediated catabolism, alleviated endoplasmic reticulum stress, and regulated autophagy balance. They also enhanced mitochondrial function and biogenesis. Transcriptomic and CMap analyses suggested PSMB1 as a potential target. In vitro, OA and UA improved mitochondrial respiration, ATP production, and glucose uptake. Overall, OA and UA effectively mitigate HFD-induced muscle atrophy through coordinated regulation of insulin signaling, proteostasis, and mitochondrial function.
- 24 October 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (43) , 33872-33887
Oleanolic Acid and Ursolic Acid Alleviate Obesity-Induced Skeletal Muscle Atrophy via Activation of the IRS/PI3K/AKT/mTOR Signaling Pathway and Attenuation of Oxidative Stress
Oleanolic acid (OA) and ursolic acid (UA) are dietary pentacyclic triterpenoids with anti-inflammatory and insulin-sensitizing properties, but their comparative effects on obesity-related skeletal muscle atrophy remain unclear. In this study, high-fat diet-fed C57BL/6J mice and palmitic acid-treated C2C12 cells were used to evaluate their efficacy and mechanisms. OA and UA improved glucose homeostasis, attenuated muscle atrophy, and alleviated dyslipidemia and inflammation. Mechanistically, both compounds activated IRS/AKT/mTOR signaling, suppressed GSK-3β/FOXO1-mediated catabolism, alleviated endoplasmic reticulum stress, and regulated autophagy balance. They also enhanced mitochondrial function and biogenesis. Transcriptomic and CMap analyses suggested PSMB1 as a potential target. In vitro, OA and UA improved mitochondrial respiration, ATP production, and glucose uptake. Overall, OA and UA effectively mitigate HFD-induced muscle atrophy through coordinated regulation of insulin signaling, proteostasis, and mitochondrial function.
- 19 July 2026
- Published by Taylor & Francis in Food Reviews International
- p. 1-28
A Comprehensive Review of the Therapeutic and Pharmacological Effects of Polygonati Rhizoma in Type 2 Diabetes Mellitus and Its Complications
Diabetes mellitus (DM) is a common clinical metabolic disease, which is characterized by abnormal hyperglycemia or insulin resistance caused by insufficient insulin secretion and insulin receptor d...
- 19 July 2026
- Published by Taylor & Francis in Food Reviews International
- p. 1-28
A Comprehensive Review of the Therapeutic and Pharmacological Effects of Polygonati Rhizoma in Type 2 Diabetes Mellitus and Its Complications
Diabetes mellitus (DM) is a common clinical metabolic disease, which is characterized by abnormal hyperglycemia or insulin resistance caused by insufficient insulin secretion and insulin receptor d...
- Open Access
- 15 July 2026
- Published by Wiley in Phytotherapy Research
- Vol. 40 (11) , 6154-6172
Transcriptome Inference and Systematic Approaches to Investigate TCM Compounds With Beneficial Metabolic Effects
Obesity is a major risk factor for type 2 diabetes. Some traditional Chinese medicine (TCM) compounds can improve obesity by increasing energy consumption. This study aimed to identify and verify TCM compounds that promote adipose thermogenesis to alleviate obesity via transcriptomic analysis, molecular docking, network pharmacology, and Connectivity Map (CMap) analysis. Thirty‐six TCMs related to adipose tissue thermogenesis were first collected to generate transcriptomic data. Then a ranking method based on integrated transcriptomic data was used to select emodin from the TCM Da Huang for network pharmacology to explore its potential mechanisms and further experimental validation. CMap analysis of thermogenesis signature genes from ProFAT and GEO datasets identified triptolide as another compound for improving obesity through enhanced thermogenesis. In vitro experiments with 3T3‐L1 cells and in vivo experiments with zebrafish were conducted. The results showed that both emodin and triptolide could upregulate the NAD + /NADH ratio, increase AMPK and SIRT1 expression, suppress lipid accumulation, and promote lipolysis, as verified by both in vitro and in vivo experiments. They also upregulated thermogenesis‐related genes (e.g., UCP1, PGC1α, and PRDM16), lipolysis‐related genes (e.g., PKA, ATGL, and HSL), mitochondrial biogenesis‐related genes (e.g., NRF1, NRF2, and TFAM), and β‐oxidation‐related genes (e.g., CPT1α and CPT1β). Meanwhile, they downregulated lipogenesis‐related genes such as FASN, SREBP1, and ACC. These results provide a basis for understanding the effects of emodin and triptolide on obesity. The findings highlight the effectiveness of combined screening approaches in exploring compounds with beneficial metabolic effects.
- 15 July 2026
- Published by Wiley in Phytotherapy Research
- Vol. 40 (11) , 6154-6172
Open AccessTranscriptome Inference and Systematic Approaches to Investigate TCM Compounds With Beneficial Metabolic Effects
Obesity is a major risk factor for type 2 diabetes. Some traditional Chinese medicine (TCM) compounds can improve obesity by increasing energy consumption. This study aimed to identify and verify TCM compounds that promote adipose thermogenesis to alleviate obesity via transcriptomic analysis, molecular docking, network pharmacology, and Connectivity Map (CMap) analysis. Thirty‐six TCMs related to adipose tissue thermogenesis were first collected to generate transcriptomic data. Then a ranking method based on integrated transcriptomic data was used to select emodin from the TCM Da Huang for network pharmacology to explore its potential mechanisms and further experimental validation. CMap analysis of thermogenesis signature genes from ProFAT and GEO datasets identified triptolide as another compound for improving obesity through enhanced thermogenesis. In vitro experiments with 3T3‐L1 cells and in vivo experiments with zebrafish were conducted. The results showed that both emodin and triptolide could upregulate the NAD + /NADH ratio, increase AMPK and SIRT1 expression, suppress lipid accumulation, and promote lipolysis, as verified by both in vitro and in vivo experiments. They also upregulated thermogenesis‐related genes (e.g., UCP1, PGC1α, and PRDM16), lipolysis‐related genes (e.g., PKA, ATGL, and HSL), mitochondrial biogenesis‐related genes (e.g., NRF1, NRF2, and TFAM), and β‐oxidation‐related genes (e.g., CPT1α and CPT1β). Meanwhile, they downregulated lipogenesis‐related genes such as FASN, SREBP1, and ACC. These results provide a basis for understanding the effects of emodin and triptolide on obesity. The findings highlight the effectiveness of combined screening approaches in exploring compounds with beneficial metabolic effects.
- Open Access
- 6 July 2026
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 66 (32) , 7043-7070
Toward human-relevant toxicology: a decision-oriented roadmap integrating modern tools for the safety evaluation of novel foods, functional ingredients, and nutraceuticals
Zero hunger is a key Sustainable Development Goal proposed by the United Nations for 2030, calling for worldwide cooperation to eradicate hunger and improve nutrition (United Nations 2015). Yet, th...
- 6 July 2026
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 66 (32) , 7043-7070
Open AccessToward human-relevant toxicology: a decision-oriented roadmap integrating modern tools for the safety evaluation of novel foods, functional ingredients, and nutraceuticals
Zero hunger is a key Sustainable Development Goal proposed by the United Nations for 2030, calling for worldwide cooperation to eradicate hunger and improve nutrition (United Nations 2015). Yet, th...
- Open Access
- 13 June 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 371, 121993
Corrigendum to “Integrated multi-omics analysis unveils biochemical mechanism of triterpenoid-enriched extract from Cynomorium songaricum against obesity and insulin resistance” [J. Ethnopharmacol. 369 (2026) 121856]
- 13 June 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 371, 121993
Open AccessCorrigendum to “Integrated multi-omics analysis unveils biochemical mechanism of triterpenoid-enriched extract from Cynomorium songaricum against obesity and insulin resistance” [J. Ethnopharmacol. 369 (2026) 121856]
- Open Access
- 7 April 2026
- Published by Elsevier in SSRN Electronic Journal
Zishen Yuzhen Pill protects against diabetic nephropathy via modulating PI3K/AKT/p38 MAPK pathway
Ethnopharmacological relevance: As a frequent complication of type 2 diabetes, diabetic nephropathy (DN) is the leading cause of mortality among affected individuals. DN is categorized under “thirsting,” “edema,” and “turbid urine” in traditional Chinese medicine (TCM). Zishen Yuzhen Pill (ZYP), a traditional Chinese medicine preparation containing 14 distinct herbs, has been clinically prescribed to DN. Nevertheless, the underlying mechanisms of ZYP ameliorates DN still unclear.Purpose: To investigate the protective effects of ZYP on DN in vivo and in vitro, and to unveil its underlying mechanism.Methods: Network analysis was carried out to identify the primary target of ZYP in treating DN. Subsequently, the therapeutic efficacy of ZYP (2.34, 4.68 g/kg) was evaluated in db/db mice. Following drug administration for 6 weeks, blood and kidney tissue were collected for analysis. Biochemical markers and metabolic parameters were detected using commercial kits. Histopathological staining was performed to monitor morphological changes of kidneys in mice. High glucose (50 mM) induced-HK-2 cells were used to evaluate the kidney protective effects of Ginsenoside Re (an active compound of ZYP). The action mechanism of ZYP was verified by western blotting and immunofluorescence. Furthermore, the target binding interaction was rigorously validated through molecular docking, molecular dynamics simulation (MD) and the cellular thermal shift assay (CETSA).Results: Through network pharmacology, ZYP exerted therapeutic effects against DN through multiple pathways, including PI3K/AKT, MAPK and TNF signaling pathway. In vivo experimental data revealed that ZYP exerted the ability to regulate the disorder in glucose/lipid metabolism, inflammatory response, oxidative stress and apoptosis, and improve kidney dysfunction. Additionally, ZYP alleviated the histopathological damage and significantly upregulated the phosphorylation of PI3K and AKT, and down regulated P38 phosphorylation in kidney tissues. According to molecular docking results, Ginsenoside Re exhibited a high binding affinity towards the targets ALB, TNF, AKT and PI3K. In vitro experimental studies demonstrated that Ginsenoside Re markedly elevated intracellular levels of glutathione (GSH) and catalase (CAT), while reducing reactive oxygen species (ROS) and malondialdehyde (MDA). It also enhanced interleukin-10 (IL-10) while suppressing interleukin-6 (IL-6) and tumor necrosis factor (TNF-a). Mechanistic study indicated that Ginsenoside Re promoted the phosphorylation of PI3K and AKT proteins and decreased the level of p-P38 protein. MD and CETSA further demonstrated a robust binding affinity between the Ginsenoside Re and the core target. Moreover, its restorative effect was abolished by a PI3K inhibitor.Conclusion: This study provides evidence that ZYP improves DN by inhibiting the inflammatory response, oxidative stress and apoptosis via the PI3K/AKT/p38 MAPK signaling pathway.
- 7 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessZishen Yuzhen Pill protects against diabetic nephropathy via modulating PI3K/AKT/p38 MAPK pathway
Ethnopharmacological relevance: As a frequent complication of type 2 diabetes, diabetic nephropathy (DN) is the leading cause of mortality among affected individuals. DN is categorized under “thirsting,” “edema,” and “turbid urine” in traditional Chinese medicine (TCM). Zishen Yuzhen Pill (ZYP), a traditional Chinese medicine preparation containing 14 distinct herbs, has been clinically prescribed to DN. Nevertheless, the underlying mechanisms of ZYP ameliorates DN still unclear.Purpose: To investigate the protective effects of ZYP on DN in vivo and in vitro, and to unveil its underlying mechanism.Methods: Network analysis was carried out to identify the primary target of ZYP in treating DN. Subsequently, the therapeutic efficacy of ZYP (2.34, 4.68 g/kg) was evaluated in db/db mice. Following drug administration for 6 weeks, blood and kidney tissue were collected for analysis. Biochemical markers and metabolic parameters were detected using commercial kits. Histopathological staining was performed to monitor morphological changes of kidneys in mice. High glucose (50 mM) induced-HK-2 cells were used to evaluate the kidney protective effects of Ginsenoside Re (an active compound of ZYP). The action mechanism of ZYP was verified by western blotting and immunofluorescence. Furthermore, the target binding interaction was rigorously validated through molecular docking, molecular dynamics simulation (MD) and the cellular thermal shift assay (CETSA).Results: Through network pharmacology, ZYP exerted therapeutic effects against DN through multiple pathways, including PI3K/AKT, MAPK and TNF signaling pathway. In vivo experimental data revealed that ZYP exerted the ability to regulate the disorder in glucose/lipid metabolism, inflammatory response, oxidative stress and apoptosis, and improve kidney dysfunction. Additionally, ZYP alleviated the histopathological damage and significantly upregulated the phosphorylation of PI3K and AKT, and down regulated P38 phosphorylation in kidney tissues. According to molecular docking results, Ginsenoside Re exhibited a high binding affinity towards the targets ALB, TNF, AKT and PI3K. In vitro experimental studies demonstrated that Ginsenoside Re markedly elevated intracellular levels of glutathione (GSH) and catalase (CAT), while reducing reactive oxygen species (ROS) and malondialdehyde (MDA). It also enhanced interleukin-10 (IL-10) while suppressing interleukin-6 (IL-6) and tumor necrosis factor (TNF-a). Mechanistic study indicated that Ginsenoside Re promoted the phosphorylation of PI3K and AKT proteins and decreased the level of p-P38 protein. MD and CETSA further demonstrated a robust binding affinity between the Ginsenoside Re and the core target. Moreover, its restorative effect was abolished by a PI3K inhibitor.Conclusion: This study provides evidence that ZYP improves DN by inhibiting the inflammatory response, oxidative stress and apoptosis via the PI3K/AKT/p38 MAPK signaling pathway.
- Top Cited Papers
- 3 March 2026
- Published by Elsevier in Carbohydrate Polymers
- Vol. 381, 125160
Supramolecular self-assembly of an herbal fructan and chitosan hydrogel: analysis of the fructan, gel structures and the molecular interaction mechanisms
- 3 March 2026
- Published by Elsevier in Carbohydrate Polymers
- Vol. 381, 125160
Top Cited PapersSupramolecular self-assembly of an herbal fructan and chitosan hydrogel: analysis of the fructan, gel structures and the molecular interaction mechanisms
- Open Access
- 3 March 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (3) , 324
Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation
Background/Objectives: ATPase family AAA domain-containing protein 2 (ATAD2) is an oncogenic chromatin regulator that amplifies E2F/MYC transcriptional programs, yet direct modulators remain scarce. Arecoline (ARE), the primary alkaloid of the areca nut, is a known carcinogen but paradoxically exhibits context-dependent anti-proliferative activities. In this study, we resolve this paradox by defining ARE’s anti-cancer mechanism. Methods: Breast cancer cell proliferation and colony formation assays were performed to evaluate the anti-proliferative effects of ARE. Cell-cycle distribution was analyzed to determine phase-specific effects. Transcriptomic profiling was conducted to identify affected gene networks. An unbiased Cellular Thermal Shift Assay–Mass Spectrometry (CETSA-MS) screening was used to identify direct protein targets, followed by CETSA–Western blotting for validation. Finally, in silico structure-based design was applied to generate novel derivatives with improved predicted properties. Results: ARE suppressed breast cancer cell proliferation and colony formation by inducing G1/S phase arrest. Transcriptomic analysis revealed that this phenotype was driven by profound suppression of the E2F/Cell Cycle gene network. CETSA-MS identified ATAD2 through multi-omics convergence, as the 67 direct targets were collectively most significantly enriched in the E2F pathway. CETSA–Western blotting confirmed that ARE binds and thermally stabilizes ATAD2. Mechanistically, ARE engagement of ATAD2 led to downregulation of key downstream proteins, including MYC and Cyclin D1, directly linking target modulation to G1/S arrest. Structure-based design further yielded novel derivatives with predicted enhanced ATAD2 binding and substantially reduced toxicity. Conclusions: Together, these findings uncover ATAD2 as a druggable target of ARE, establish proof-of-concept for repurposing this scaffold, and provide a rational framework for developing safer ATAD2-targeted therapies.
- 3 March 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (3) , 324
Open AccessArecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation
Background/Objectives: ATPase family AAA domain-containing protein 2 (ATAD2) is an oncogenic chromatin regulator that amplifies E2F/MYC transcriptional programs, yet direct modulators remain scarce. Arecoline (ARE), the primary alkaloid of the areca nut, is a known carcinogen but paradoxically exhibits context-dependent anti-proliferative activities. In this study, we resolve this paradox by defining ARE’s anti-cancer mechanism. Methods: Breast cancer cell proliferation and colony formation assays were performed to evaluate the anti-proliferative effects of ARE. Cell-cycle distribution was analyzed to determine phase-specific effects. Transcriptomic profiling was conducted to identify affected gene networks. An unbiased Cellular Thermal Shift Assay–Mass Spectrometry (CETSA-MS) screening was used to identify direct protein targets, followed by CETSA–Western blotting for validation. Finally, in silico structure-based design was applied to generate novel derivatives with improved predicted properties. Results: ARE suppressed breast cancer cell proliferation and colony formation by inducing G1/S phase arrest. Transcriptomic analysis revealed that this phenotype was driven by profound suppression of the E2F/Cell Cycle gene network. CETSA-MS identified ATAD2 through multi-omics convergence, as the 67 direct targets were collectively most significantly enriched in the E2F pathway. CETSA–Western blotting confirmed that ARE binds and thermally stabilizes ATAD2. Mechanistically, ARE engagement of ATAD2 led to downregulation of key downstream proteins, including MYC and Cyclin D1, directly linking target modulation to G1/S arrest. Structure-based design further yielded novel derivatives with predicted enhanced ATAD2 binding and substantially reduced toxicity. Conclusions: Together, these findings uncover ATAD2 as a druggable target of ARE, establish proof-of-concept for repurposing this scaffold, and provide a rational framework for developing safer ATAD2-targeted therapies.